<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="becoming pandemic. Currently, there is still no licensed specific antiviral" exact="treatment" post="for the human coronavirus disease and a vaccine will"/>
 <result pre="use of other antiviral agents to treat similar virusses, some" exact="treatment" post="options have been tried with some efficacy. Clinical trials"/>
 <result pre="are the only ways to overcome this challenge. Keywords Antiviral" exact="treatment" post="Coronavirus COVID-19 SARS-CoV-2 Since 31 December 2019, COVID-19, the"/>
 <result pre="cluster [6]. Currently, there is still no licensed specific antiviral" exact="treatment" post="for the human coronavirus disease and a vaccine will"/>
 <result pre="against SARS-COV, the second-generation protease inhibitor lopinavir, approved for the" exact="treatment" post="of HIV in combination with a low dose of"/>
 <result pre="comparing a group of patients treated with lopinavir/ritonavir and standard" exact="treatment" post="(nâ€‰=â€‰99) versus a second group treated with standard treatment"/>
 <result pre="standard treatment (nâ€‰=â€‰99) versus a second group treated with standard" exact="treatment" post="alone (nâ€‰=â€‰100) [12] showed that the use of lopinavirâ€&quot;ritonavir"/>
 <result pre="use of lopinavirâ€&quot;ritonavir association had no benefit compared to standard" exact="treatment" post="alone [12]. The standard treatment was based on the"/>
 <result pre="no benefit compared to standard treatment alone [12]. The standard" exact="treatment" post="was based on the administration of oxygen, invasive and"/>
 <result pre="that interferon-Î±, a broad spectrum antiviral drug used for the" exact="treatment" post="of hepatitis, administered by inhalation is also helpful in"/>
 <result pre="useful therapy, together with the antimalarial chloroquine and the antiviral" exact="treatment" post="for influenza arbidol, the broad-spectrum antiviral agent Ribavirin, a"/>
 <result pre="effect can be explained by the inhibition of IMPÎ±/Î²1 during" exact="infection" post="impacting on cell division [22]. So far, researchers have"/>
 <result pre="(TMPRSS2) inhibitors like camostat mesilate, approved in Japan for the" exact="treatment" post="of pancreatic inflammation [10]. This drug could act by"/>
 <result pre="2019 coronavirusAntimicrob Agents Chemother202064e0039910.1128/AAC.00399-2032152082 11.ChuCMChengVCHungIFet al.Role of LOPINAVIR/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax200459325225610.1136/thorax.2003.01265814985565 12.CaoBWangYWenDLiuWWangJet al.Trial"/>
 <result pre="in ChinaJ Med Virol20209254054510.1002/jmv.25733 16.GautretPLagierJCParolaPet al.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
 <result pre="Antimicrob Agents202010.1016/j.ijantimicag.2020.10593832179150 19.AmsdenGWAnti-inflammatory effects of macrolidesâ€&quot;an underappreciated benefit in the" exact="treatment" post="of community-acquired respiratory tract infections and chronic inflammatory pulmonary"/>
</results>
